US2014056822A1PendingUtilityA1

DNA Dendrimers as Thermal Ablation Devices

49
Assignee: GENISPHERE LLCPriority: Feb 24, 2010Filed: Nov 6, 2013Published: Feb 27, 2014
Est. expiryFeb 24, 2030(~3.6 yrs left)· nominal 20-yr term from priority
A61P 35/00A61N 5/062A61K 47/6923A61P 31/00A61P 35/02A61K 47/6935A61P 35/04G01N 33/56966A61K 41/0052A61K 49/124A61K 47/4823
49
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

DNA dendrimers for targeted delivery of radiation absorbing nanoparticles and thermal ablation of cells and tissues are provided. Also provided are methods of making and methods of using the DNA dendrimers.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method of thermally ablating cells or tissues comprising:
 a) contacting the cells or tissues with a DNA dendrimer linked to at least one radiation absorbing nanoparticle and at least one targeting moiety such that the targeting moiety binds to a complementary target on the surface of cells or tissues; and   b) exposing the cells or tissues with the bound DNA dendrimer to externally applied electromagnetic radiation at a power and for a time sufficient to cause nanoparticles linked to the DNA dendrimer to emit heat, thereby resulting in thermal ablation of cells or tissues bound to the DNA dendrimer.   
     
     
         2 . The method of  claim 1 , wherein the at least one radiation absorbing nanoparticle is a carbon-based nanoparticle or a metallic nanoparticle. 
     
     
         3 . The method of  claim 2 , wherein the at least one radiation absorbing nanoparticle is a gold nanoparticle. 
     
     
         4 . The method of  claim 1 , wherein the electromagnetic radiation applied is RF radiation. 
     
     
         5 . The method of  claim 1 , wherein the cells or tissues are contacted with the DNA dendrimer in vivo or ex vivo. 
     
     
         6 . The method of  claim 1 , wherein the cells or tissues are selected from the group consisting of solid tumors, circulating tumor cells, cancer metastases, microorganisms and biological materials for transplantation. 
     
     
         7 . The method of  claim 1 , wherein components of the DNA dendrimer are administered separately and allowed to assemble post-administration on the cells or tissues. 
     
     
         8 . The method of  claim 1 , wherein the DNA dendrimer is parenterally administered to a human. 
     
     
         9 . The method of  claim 8 , further comprising monitoring a location of the DNA dendrimer using a tracking label linked to the DNA dendrimer. 
     
     
         10 . A method for imaging cells or tissues comprising:
 a) contacting the cells or tissues with a DNA dendrimer linked to at least one radiation absorbing nanoparticle and at least one targeting moiety such that the targeting moiety binds to a complementary target on the surface of cells or tissues, wherein the DNA dendrimer comprises at least one metallic radiation absorbing nanoparticle; and   b) imaging the cells or tissues using the metallic radiation absorbing nanoparticle bound to the cells or tissues.   
     
     
         11 . The method of  claim 10 , wherein the at least one radiation absorbing nanoparticle is a gold nanoparticle. 
     
     
         12 . The method of  claim 10 , wherein the cells or tissues are imaged using reflective imaging, photothermal interference contrast, dark-field imaging, scanning electron microscopy, fluorescence microscopy, photoacoustic tomography, optical coherence tomography, magnetic resonance imaging, or Raman spectroscopy. 
     
     
         13 . The method of  claim 10  wherein components of the DNA dendrimer are administered separately and allowed to assemble post-administration on the cells or tissues. 
     
     
         14 . The method of  claim 10  wherein the cells or tissues are contacted in vivo.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.